Incorporated in 2016, Nureca Ltd is in the business of Home Healthcare and Wellness Products.[1]
Business Overview:[1][2]NL is a digitally first, consumer healthcare company with presence in categories suchas home diagnostics, wellness devices, and personal fitness equipment under brands likeDr Trust and Dr Physio. The company has277+ Active SKUs, and7New Products were launched during Q1FY26
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Poly Medicure | 1787.60 | 50.06 | 18119.02 | 0.20 | 91.80 | 5.02 | 443.88 | 5.68 | 20.08 | 1712.13 | 26.54 | 361.98 | 91.84 | 6.21 | 13.23 | 0.08 |
| 2. | Fischer Medical | 41.43 | 133.80 | 2686.80 | 0.01 | 13.90 | 2928.26 | 86.31 | 117.62 | 1.08 | 170.67 | 13.70 | 20.08 | 13.93 | 7.46 | 0.44 | 0.08 |
| 3. | Laxmi Dental | 259.90 | 55.45 | 1428.47 | 0.00 | 8.53 | 44.82 | 72.27 | 26.52 | 19.20 | 260.21 | 16.17 | 25.76 | 8.53 | 6.23 | 12.31 | 0.04 |
| 4. | Tarsons Products | 230.28 | 59.59 | 1225.23 | 0.00 | 3.32 | -67.74 | 102.33 | 3.10 | 6.91 | 402.06 | 29.55 | 20.56 | 3.32 | 1.96 | 2.88 | 0.63 |
| 5. | Vasa Denticity | 591.90 | 63.46 | 1026.17 | 0.00 | 4.99 | -7.08 | 72.72 | 22.44 | 23.17 | 268.37 | 7.93 | 16.17 | 4.99 | 6.00 | 14.51 | 0.00 |
| 6. | OSEL Devices | 544.35 | 35.37 | 963.21 | 0.00 | 15.19 | 89.64 | 146.86 | 68.13 | 31.14 | 245.98 | 18.14 | 27.23 | 15.19 | 5.44 | 13.53 | 0.56 |
| 7. | Prevest Denpro | 491.00 | 29.60 | 589.35 | 0.20 | 5.57 | 15.08 | 18.66 | 14.76 | 25.25 | 67.85 | 35.37 | 19.91 | 5.57 | 5.09 | 17.54 | 0.00 |
| 8. | Nureca | 296.50 | 120.04 | 296.51 | 0.00 | 3.14 | 583.08 | 37.84 | 16.90 | 0.33 | 131.12 | -2.01 | 2.47 | 3.14 | 1.51 | -0.34 | 0.02 |
| – | Median: 13 Co. | 279.2 | 42.87 | 589.35 | 0.0 | 5.41 | 28.46 | 64.26 | 20.16 | 19.2 | 170.67 | 16.66 | 19.91 | 5.41 | 5.27 | 12.31 | 0.08 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 27.84 | 22.37 | 27.21 | 21.23 | 23.31 | 34.32 | 21.22 | 19.56 | 31.75 | 36.79 | 31.35 | 32.37 | 37.84 |
Expenses | 29.08 | 26.80 | 31.95 | 24.22 | 26.23 | 35.40 | 25.03 | 24.32 | 31.19 | 41.63 | 30.31 | 35.03 | 35.22 |
Operating Profit | -1.24 | -4.43 | -4.74 | -2.99 | -2.92 | -1.08 | -3.81 | -4.76 | 0.56 | -4.84 | 1.04 | -2.66 | 2.62 |
Other Income | 1.92 | 5.92 | 1.52 | 2.69 | 5.82 | 2.59 | 2.15 | -1.25 | 2.00 | 1.91 | 3.21 | 3.21 | 2.38 |
Profit before tax | 0.00 | 0.83 | -3.85 | -0.97 | 2.16 | 0.83 | -2.30 | -6.74 | 1.49 | -3.63 | 3.61 | -0.27 | 4.11 |
Tax % | – | 90.36% | -14.55% | -22.68% | 44.91% | 33.73% | -21.74% | -34.57% | -38.93% | -23.14% | 26.87% | 140.74% | 23.60% |
Net Profit | 0.03 | 0.08 | -3.29 | -0.74 | 1.20 | 0.55 | -1.80 | -4.41 | 2.07 | -2.78 | 2.64 | -0.65 | 3.14 |
EPS in Rs | 0.03 | 0.08 | -3.29 | -0.74 | 1.20 | 0.55 | -1.80 | -4.41 | 2.07 | -2.78 | 2.64 | -0.65 | 3.14 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
Sales | 0 | 1 | 1 | 99 | 213 | 256 | 112 | 95 | 115 | 131 |
Expenses | 0 | 1 | 1 | 90 | 152 | 200 | 127 | 106 | 124 | 134 |
Operating Profit | 0 | 0 | 0 | 10 | 62 | 56 | -15 | -11 | -10 | -3 |
Other Income | 0 | 0 | 0 | 0 | 3 | 8 | 7 | 11 | 13 | 8 |
Interest | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 1 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 |
Profit before tax | 0 | 0 | 0 | 9 | 62 | 61 | -11 | -3 | -0 | 3 |
Net Profit | 0 | 0 | 0 | 6 | 47 | 45 | -8 | -2 | -1 | 2 |
EPS in Rs | 0.00 | 20.00 | 20.00 | 6,410.00 | 46.53 | 45.31 | -8.42 | -2.44 | -0.67 | 2.47 |
Dividend Payout % | – | 0% | 0% | 0% | 4% | 7% | 0% | 0% | 0% | – |
Standalone figures in ₹ crores
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.01 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | 0 | 0 | 0 | 15 | 153 | 194 | 185 | 183 | 182 | 186 |
Borrowings | 0 | 0 | 0 | 10 | 4 | 4 | 3 | 2 | 4 | 3 |
Other Liabilities | 0 | 0 | 1 | 9 | 19 | 11 | 8 | 9 | 10 | 14 |
Total Liabilities | 0 | 0 | 1 | 34 | 186 | 220 | 207 | 204 | 206 | 213 |
Fixed Assets | 0 | 0 | 0 | 1 | 3 | 10 | 8 | 6 | 8 | 13 |
Gross Block | 0.00 | 0.00 | 0.06 | 1.44 | 4.16 | 10.48 | 9.87 | 9.15 | 11.53 | – |
Accumulated Depreciation | 0.00 | 0.00 | 0.00 | 0.37 | 0.79 | 0.70 | 1.79 | 2.82 | 3.73 | – |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 1 | 34 | 62 | 97 | 4 | 11 |
Other Assets | 0 | 0 | 1 | 33 | 181 | 175 | 136 | 101 | 194 | 189 |
Total Assets | 0 | 0 | 1 | 34 | 186 | 220 | 207 | 204 | 206 | 213 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | -0 | – | – | -8 | 35 | 2 | 12 | -3 | -19 |
Cash from Investing Activity | 0 | – | – | -0 | -110 | -3 | -18 | 18 | 9 |
Cash from Financing Activity | 0 | – | – | 8 | 92 | -7 | -2 | -1 | -1 |
Net Cash Flow | 0 | – | – | -0 | 17 | -9 | -8 | 14 | -11 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365 | 87 | 65 | 47 | 0 | 4 | 14 | 7 | 14 |
Inventory Days | 0 | 101 | 590 | 93 | 135 | 174 | 154 | 156 | 163 |
Days Payable | – | 233 | 849 | 33 | 32 | 13 | 23 | 27 | 26 |
Cash Conversion Cycle | 365 | -45 | -195 | 107 | 103 | 165 | 145 | 136 | 151 |
Working Capital Days | 182 | -12 | -45 | 85 | 61 | 109 | 148 | 160 | 403 |
ROCE % | – | 100% | 75% | 76% | 67% | 33% | -5% | -1% | 0% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
No credit ratings.
Stock Analysis
Nureca Limited is a digitally-first consumer healthcare company specializing in home diagnostics, wellness, and personal fitness equipment under brands like Dr Trust and Dr Physio.
Currently no data available for Order Book.
Corporate Announcements
